Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 78.90
+2.70 (3.54%)
Sep 18, 2026, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 13.21 billion as of September 18, 2026. Its market cap has decreased by -75.33% in one year.
Market Cap
13.21B
Enterprise Value
12.59B
Revenue
34.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
78.90
ChartMarket Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 13.21B, an increase of 207.68%. That is a compound annual growth rate of 10.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 13.21B | -59.67% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 19.96B |
| CHO Pharma | 18.73B |
| Gongwin Biopharm Holdings | 17.32B |
| TaiMed Biologics | 17.08B |
| Ever Supreme Bio Technology | 15.92B |
| EirGenix | 15.29B |
| ACRO Biomedical | 14.62B |
| Steminent Biotherapeutics | 12.65B |